secwatch.observer — SEC 8-K summary
======================================

Issuer:     ENDRA Life Sciences Inc. (NDRA)
CIK:        0001681682
Form:       8-K
Filed at:   2023-07-25T23:59:59+00:00
Accession:  0001654954-23-009661
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

ENDRA Life Sciences adjourns annual meeting to Aug. 9 due to lack of quorum
---------------------------------------------------------------------------

- Annual meeting reconvened July 25, 2023 and again adjourned for lack of quorum; new date Aug. 9, 2023 at 10:00 AM ET.
- Stockholders who already voted need not recast; proxies remain valid unless revoked.
- Voting deadline extended to Aug. 8, 2023 at 11:59 PM ET; company continues solicitation.
- Meeting was first commenced and adjourned on July 6, 2023 for same reason.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1681682/000165495423009661/0001654954-23-009661-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1681682/000165495423009661/ndra_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-23-009661

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer